Funded Startups in Beijing
Beijing's recent funding activity spans aerospace, artificial intelligence, healthcare, and energy, with 24 of the 27 rounds in this dataset closing betwee…
Beijing's recent funding activity spans aerospace, artificial intelligence, healthcare, and energy, with 24 of the 27 rounds in this dataset closing between September 14 and November 30, 2025. The two largest disclosed rounds both come from aerospace: Galactic Energy Aerospace Technology raised $336M at Series D on October 2, and Tianbing Technology raised $351M at Series D on October 11 — together totaling $687M in aerospace funding within a single month.
Artificial intelligence appears across multiple verticals — Infinigence ($71M, Series A, November 27) and AIsphere ($60M, Series B, September 12) are the largest AI-focused rounds in this set. Series A is the most common disclosed stage, represented by seven companies including Xingchen New Energy ($42M), Lingxin Qiaoshou ($14M), and QuickCEP. Healthcare and biotech show consistent presence throughout the period, with rounds from LASO Biotech, Leadinno Medical Valley ($28M, Series B), Taihao Biotechnology, Deepwise, and CytoNiche spread across September through November 2025.
Most recent rounds
27 shownRelated listings
Frequently asked
What are the largest recent funding rounds among Beijing startups in this dataset?
The two largest rounds are both Series D aerospace raises from October 2025: Tianbing Technology at $351M (October 11) and Galactic Energy Aerospace Technology at $336M (October 2). The next largest disclosed rounds are Infinigence at $71M (Series A, AI/cloud computing) and AIsphere at $60M (Series B, AI/media), both closing in the September–November 2025 window.
Which sectors dominate Beijing's recent funding activity?
Aerospace and artificial intelligence account for the largest round sizes. Aerospace is represented by Tianbing Technology, Galactic Energy Aerospace Technology, and Hangxing Transmission. AI appears across robotics (Lingxin Qiaoshou, Booster Robotics), cloud infrastructure (Infinigence), and B2B marketing (QuickCEP, PureblueAI). Healthcare and biotech have the broadest company count, with LASO Biotech, Deepwise, Taihao Biotechnology, Leadinno Medical Valley, Huamei Haolian, and CytoNiche all raising within the same period.
What is the funding stage breakdown across these Beijing companies?
Series A is the most common stage, covering seven companies: Lingxin Qiaoshou, Infinigence, QuickCEP, Billy Information, Taihao Biotechnology, Xingchen New Energy, and Hangxing Transmission. Series B follows with six companies, and Seed accounts for four — Zhongchuang Zhiyuan, Makera, Maimai Technology, and PureblueAI. Three companies — Tianbing Technology, Galactic Energy Aerospace Technology, and Beijing Weilan New Energy Technology — are at Series D.
How many of these rounds have undisclosed amounts?
Twelve of the 27 entries do not disclose a round size, including LASO Biotech, QuickCEP, Billy Information, Deepwise, Taihao Biotechnology, Senior Auto, Hangxing Transmission, Beijing Weilan New Energy Technology, Huamei Haolian, CytoNiche, Makera, and Zhongchuang Zhiyuan. The remaining 15 entries have disclosed amounts ranging from PureblueAI's $1M seed to Tianbing Technology's $351M Series D.
When did most of the funding activity in this dataset occur?
Twenty-four of the 27 rounds closed between September 14 and November 30, 2025. November alone accounts for 11 rounds. October was dominated by aerospace, with Tianbing Technology and Galactic Energy Aerospace Technology both closing Series D rounds within a nine-day span, together totaling $687M.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.